Search alternatives:
improved decrease » improved urease (Expand Search)
significant i.e » significant inter (Expand Search), significant bias (Expand Search), significant gap (Expand Search)
marked decrease » marked increase (Expand Search)
i.e decrease » we decrease (Expand Search), sizes decrease (Expand Search), teer decrease (Expand Search)
improved decrease » improved urease (Expand Search)
significant i.e » significant inter (Expand Search), significant bias (Expand Search), significant gap (Expand Search)
marked decrease » marked increase (Expand Search)
i.e decrease » we decrease (Expand Search), sizes decrease (Expand Search), teer decrease (Expand Search)
-
1
-
2
-
3
-
4
-
5
-
6
-
7
-
8
-
9
-
10
Socio-demographic characteristics of hypertensive patients’ caregivers (n = 422).
Published 2025Subjects: -
11
-
12
-
13
-
14
-
15
-
16
-
17
Image 3_Endolysin significantly improves symptoms with atopic dermatitis: bridging the gap from research to clinical practice.jpeg
Published 2025“…Compared to baseline, EASI, SCORAD, IGA, VAS, and DLQI scores demonstrated significant decreases at both Day 7 and Day 14 (all P < 0.05). …”
-
18
Image 4_Endolysin significantly improves symptoms with atopic dermatitis: bridging the gap from research to clinical practice.jpeg
Published 2025“…Compared to baseline, EASI, SCORAD, IGA, VAS, and DLQI scores demonstrated significant decreases at both Day 7 and Day 14 (all P < 0.05). …”
-
19
Image 2_Endolysin significantly improves symptoms with atopic dermatitis: bridging the gap from research to clinical practice.jpeg
Published 2025“…Compared to baseline, EASI, SCORAD, IGA, VAS, and DLQI scores demonstrated significant decreases at both Day 7 and Day 14 (all P < 0.05). …”
-
20
Table 2_Endolysin significantly improves symptoms with atopic dermatitis: bridging the gap from research to clinical practice.docx
Published 2025“…Compared to baseline, EASI, SCORAD, IGA, VAS, and DLQI scores demonstrated significant decreases at both Day 7 and Day 14 (all P < 0.05). …”